Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
CLBT Stock Chart & Stats
$18.30
-$0.01(-0.05%)
At close: 4:00 PM EST
$18.30
-$0.01(-0.05%)
Day’s Range― - ―
52-Week Range$13.10 - $26.30
Previous CloseN/A
Volume262.11K
Average Volume (3M)1.44M
Market Cap
$4.35B
Enterprise Value$4.12B
Total Cash (Recent Filing)$525.71M
Total Debt (Recent Filing)$21.44M
Price to Earnings (P/E)59.8
Beta0.79
Next Earnings
Feb 18, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding239,470,060
10 Day Avg. Volume1,735,726
30 Day Avg. Volume1,437,296
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)13.73
Price to Sales (P/S)11.50
P/FCF Ratio37.96
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue9.04
Enterprise Value/Gross Profit10.77
Enterprise Value/Ebitda53.30
Forecast
1Y Price Target
$24.83Price Target Upside35.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)0.35
Revenue Forecast (FY)$469.38M
Bulls Say, Bears Say
Bulls Say
EarningsCellebrite reported solid 3QCY25 results, with Revenue at the high-end of guidance and Adjusted EBITDA demonstrating material outperformance.
Federal Business ExpansionThe expansion of business in the Federal segment addresses previous concerns of Federal weakness.
Market LeadershipCellebrite is the leading provider of smartphone forensic software, with an estimated 70%-plus market share.
Bears Say
Cellebrite DI News
CLBT FAQ
What was Cellebrite DI’s price range in the past 12 months?
Cellebrite DI lowest stock price was $13.10 and its highest was $26.30 in the past 12 months.
What is Cellebrite DI’s market cap?
Cellebrite DI’s market cap is $4.35B.
When is Cellebrite DI’s upcoming earnings report date?
Cellebrite DI’s upcoming earnings report date is Feb 18, 2026 which is in 90 days.
How were Cellebrite DI’s earnings last quarter?
Cellebrite DI released its earnings results on Nov 12, 2025. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.094 by -$0.014.
Is Cellebrite DI overvalued?
According to Wall Street analysts Cellebrite DI’s price is currently Undervalued.
Does Cellebrite DI pay dividends?
Cellebrite DI does not currently pay dividends.
What is Cellebrite DI’s EPS estimate?
Cellebrite DI’s EPS estimate is 0.1.
How many shares outstanding does Cellebrite DI have?
Cellebrite DI has 239,470,060 shares outstanding.
What happened to Cellebrite DI’s price movement after its last earnings report?
Cellebrite DI reported an EPS of $0.08 in its last earnings report, missing expectations of $0.094. Following the earnings report the stock price went up 20.726%.
Which hedge fund is a major shareholder of Cellebrite DI?
Currently, no hedge funds are holding shares in CLBT
Cellebrite DI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.83 (35.68% Upside)
$24.83 (35.68% Upside)
Blogger Sentiment
Neutral
CLBT Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 338.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.75%
12-Months-Change
Fundamentals
Return on Equity
20.46%
Trailing 12-Months
Asset Growth
32.59%
Trailing 12-Months
Company Description
Cellebrite DI
Cellebrite DI (CLBT) is a global leader in digital intelligence solutions, specializing in providing tools and services for law enforcement, military, and private sector organizations to analyze and extract data from digital devices. The company operates in the fields of digital forensics and data extraction, offering a range of products that enable users to recover, analyze, and manage data from mobile devices and cloud services. Its core products include the Universal Forensic Extraction Device (UFED), which allows for comprehensive data extraction, and Analytics solutions that assist in transforming extracted data into actionable intelligence.
CLBT Company Deck
CLBT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cellebrite DI Ltd. demonstrated strong growth in ARR and subscription revenue, with significant advancements in cloud and SaaS offerings. The company successfully expanded its defense and intelligence sector presence and saw recovery in the US Federal segment. However, challenges remain in the federal segment and delays in the Keryllium acquisition process. Overall, the company is well-positioned for continued growth, with strategic initiatives in place for 2026.View all CLBT earnings summariesCLBT Stock 12 Month Forecast
Average Price Target
$24.83
▲(35.68% Upside)
Technical Analysis
Ownership Overview
―
Insiders
4.66% Mutual Funds
13.68% Other Institutional Investors
80.04% Public Companies and Individual Investors